ArticleOsteoporosis and sarcopenia2017
Trends in post osteoporotic hip fracture care from 2010 to 2014 in a private hospital in Malaysia.
Article in Osteoporosis and sarcopenia, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 18 citations in OpenAlex.
- Romosozumab or alendronate for fracture prevention in East Asian patients: a subanalysis of the phase III, randomized ARCH study.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2020Trial
- Osteoporosis treatment gap after hip fracture: data from a tertiary center in Turkey.Archives of osteoporosis · 2025Article
- Implementation of a Fracture Liaison Service in a tertiary hospital in Malaysia: a feasibility study.Archives of osteoporosis · 2024Article
- Views of healthcare professionals regarding barriers and facilitators for a Fracture Liaison Service in Malaysia.PloS one · 2024Article
- Budget impact of increasing uptake of denosumab for the treatment of postmenopausal osteoporosis in Malaysia.Archives of osteoporosis · 2023Article
- Fracture Liaison Service and Its Role in Secondary Fracture Prevention in Malaysia: A Scoping Review.Malaysian orthopaedic journal · 2023Article
- Fragility fracture care gap at a tertiary teaching hospital in Malaysia.Archives of osteoporosis · 2023Article
- Screening and management of osteoporosis: a survey of knowledge, attitude and practice among primary care physicians in Malaysia.Archives of osteoporosis · 2022Article
- The Current and Future Challenges of Hip Fracture Management in Malaysia.Malaysian orthopaedic journal · 2020Article
- Secondary prevention of fragility fractures in Asia Pacific: an educational initiative.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2020Review
- The Asian Federation of Osteoporosis Societies' call to action to improve the undertreatment of osteoporosis in Asia.Osteoporosis and sarcopenia · 2017Article
- Combined orthogeriatric and fracture liaison service for improved postfracture patient care.Osteoporosis and sarcopenia · 2017Article
- Reply on "Combined orthogeriatric and fracture liaison service for improved postfracture patient care".Osteoporosis and sarcopenia · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveFollowing an osteoporotic fracture, pharmacological treatment is recommended to increase bone mineral density and prevent future fractures. However, the rate of starting treatment after an osteoporotic hip fracture remains low. The objective of this study was to survey the treatment rate following a low-trauma hip fracture at a tertiary private hospital in Malaysia over a period of 5 years.
methodsThe computerised hospital discharge records were searched using the terms "hip," "femur," "femoral," "trochanteric," "fracture," or "total hip replacement" for all patients over the age of 50, admitted between 2010 and 2014. The medical charts were obtained and manually searched for demographic data and treatment information. Hip operations done for non-low-trauma-related fracture and arthritis were excluded.
resultsThree hundred seventy patients over the age of 50 years were admitted with a hip fracture, of which 258 (69.7%) were low trauma, presumed osteoporotic, hip fractures. The median age was 79.0 years (interquartile range [IQR], 12.0). Following a hip fracture, 36.8% (95 of 258) of the patients received treatment, but out of these, 24.2% (23 of 95) were on calcium/vitamin D only. The median duration of treatment was 1 month (IQR, 2.5). In 2010, 56.7% of the patients received treatment, significantly more than subsequent years 2011-2014, where approximately only 30% received treatment.
conclusionsFollowing a low-trauma hip fracture, approximately 72% of patients were not started on active antiosteoporosis therapy. Of those who were, the median duration of treatment was 1 month. This represents a missed opportunity for the prevention of future fractures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.